- Home
- CORT vs RVMD Comparison
CORT vs RVMD Comparison
Compare CORT & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- RVMD
- Stock Information
- Founded
- CORT 1998
- RVMD 2014
- Country
- CORT United States
- RVMD United States
- Employees
- CORT N/A
- RVMD N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CORT Health Care
- RVMD Health Care
- Exchange
- CORT Nasdaq
- RVMD Nasdaq
- Market Cap
- CORT 7.6B
- RVMD 7.5B
- IPO Year
- CORT N/A
- RVMD 2020
- Fundamental
- Price
- CORT $71.66
- RVMD $40.30
- Analyst Decision
- CORT Strong Buy
- RVMD Strong Buy
- Analyst Count
- CORT 4
- RVMD 14
- Target Price
- CORT $139.00
- RVMD $71.93
- AVG Volume (30 Days)
- CORT 640.1K
- RVMD 1.9M
- Earning Date
- CORT 10-29-2025
- RVMD 11-05-2025
- Dividend Yield
- CORT N/A
- RVMD N/A
- EPS Growth
- CORT N/A
- RVMD N/A
- EPS
- CORT 1.11
- RVMD N/A
- Revenue
- CORT $716,080,000.00
- RVMD N/A
- Revenue This Year
- CORT $30.62
- RVMD N/A
- Revenue Next Year
- CORT $37.68
- RVMD $387.56
- P/E Ratio
- CORT $64.27
- RVMD N/A
- Revenue Growth
- CORT 25.71
- RVMD N/A
- 52 Week Low
- CORT $34.34
- RVMD $29.17
- 52 Week High
- CORT $117.33
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- CORT 53.12
- RVMD 61.57
- Support Level
- CORT $67.32
- RVMD $38.49
- Resistance Level
- CORT $72.52
- RVMD $41.60
- Average True Range (ATR)
- CORT 1.92
- RVMD 1.58
- MACD
- CORT 0.14
- RVMD 0.41
- Stochastic Oscillator
- CORT 64.27
- RVMD 78.96
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.